Xavier Nassif

USPTO Granted Patents = 15 (Patent Applications = 5)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 4)

Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 45(Granted Patents)

Company Filing History:

8 out of 1,743

Institut National De La Sante Et De La Recherche Medicale

patents

4 out of 504

Oregon Health & Science University

patents

3 out of 75

Aventis Pasteur Limited

patents

4. 2 out of 1,288

Max-planck-gesellschaft Zur Forderung Der Wissenschaften E.v.

patents

5. 2 out of 132

UniversitÉ Paris Descartes

patents

6. 1 out of 2,198

Smithkline Beecham Corporation

patents

7. 1 out of 61

Assistance Publique - Hopitaux De Paris (aphp)

patents

8. 2 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1997-2018

Loading Chart...

15 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 10000545 - [object Object] (2018-06-19),

2. 8357791 - [object Object] (2013-01-22),

3. 8309100 - [object Object] (2012-11-13),

4. 8155892 - Means for identifying a strain isolated from a clinical sample at the species and/or subspecies level (2012-04-10),

5. 7704513 - [object Object] (2010-04-27),

6. 7422754 - [object Object] (2008-09-09),

7. 7384768 - [object Object] (2008-06-10),

8. 7368556 - [object Object] (2008-05-06),

9. 7029845 - DNAs and proteins or peptides specific to bacteria of the species Neisseria meningitidis, processes for obtaining them and their biological uses (2006-04-18),

10. 7026157 - Bacterial hemoglobin receptor genes (2006-04-11),

11. 6835384 - Nucleic acids and polypeptides specific of the neisseria genus pathogenic strains (2004-12-28),

12. 6277382 - Hemoglobin receptors from neisseriae (2001-08-21),

13. 6123942 - Bacterial hemoglobin receptor gene (2000-09-26),

14. 6121037 - Bacterial hemoglobin receptor genes (2000-09-19),

15. 5698438 - Bacterial hemoglobin receptor gene (1997-12-16),

Title: Innovations and Contributions of Inventor Xavier Nassif

Introduction

Xavier Nassif is a prominent inventor based in Paris, France. He has made significant contributions to the field of medical research, particularly in the prevention and treatment of meningococcal infections. With a total of 15 patents to his name, his work has had a substantial impact on public health.

Latest Patents

Among his latest patents, one invention focuses on the use of an inhibitor of the interaction between type IV pilus-associated protein and CD147. This invention aims to prevent or treat meningococcal bacteraemia and infections. Additionally, it relates to the combined use of such inhibitors with anti-bacterial compounds. Another notable patent involves DNA sequences that are part of genes related to the biosynthesis of the polysaccharide capsule and other proteins. This invention is applicable in the prevention and detection of meningococcus-induced infections and meningitis.

Career Highlights

Xavier Nassif has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and Oregon Health & Science University. His research has been pivotal in advancing our understanding of bacterial infections and developing effective treatments.

Collaborations

Throughout his career, Xavier has collaborated with notable colleagues, including Colin Tinsley and Igor Stojiljkovic. These partnerships have further enriched his research and innovations.

Conclusion

Xavier Nassif's contributions to medical research and his innovative patents demonstrate his commitment to improving health outcomes. His work continues to influence the field and offers hope for better prevention and treatment of serious infections.

This text is generated by artificial intelligence and may not be accurate.